华仁药业：将持续跟进原料药生产基地项目进展

Core Viewpoint - Huaren Pharmaceutical (300110) has signed a preliminary cooperation framework agreement with the government of Feidong County for a raw material drug production base project, which is not yet finalized in terms of specific investment amounts [1] Group 1 - The cooperation agreement is an initial intent and does not specify the investment amount at this stage [1] - If the cooperation materializes, it will enable the company to develop large-scale and intelligent raw material production capabilities [1] - This project aligns with the company's integrated strategy of "raw materials + formulations + packaging materials" [1] Group 2 - The company will continue to monitor the project's progress and fulfill relevant review procedures and information disclosure obligations in a timely manner [1]